Cargando…

Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review

Bioelectrical Impedance Analysis (BIA) is a reliable, non-invasive, objective, and cost-effective body composition assessment method, with high reproducibility. This scoping review aims to evaluate the current scientific and clinical evidence on BIA for body composition assessment in oncology patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Branco, Mariana Garcia, Mateus, Carlota, Capelas, Manuel Luís, Pimenta, Nuno, Santos, Teresa, Mäkitie, Antti, Ganhão-Arranhado, Susana, Trabulo, Carolina, Ravasco, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675768/
https://www.ncbi.nlm.nih.gov/pubmed/38004186
http://dx.doi.org/10.3390/nu15224792
_version_ 1785149852071493632
author Branco, Mariana Garcia
Mateus, Carlota
Capelas, Manuel Luís
Pimenta, Nuno
Santos, Teresa
Mäkitie, Antti
Ganhão-Arranhado, Susana
Trabulo, Carolina
Ravasco, Paula
author_facet Branco, Mariana Garcia
Mateus, Carlota
Capelas, Manuel Luís
Pimenta, Nuno
Santos, Teresa
Mäkitie, Antti
Ganhão-Arranhado, Susana
Trabulo, Carolina
Ravasco, Paula
author_sort Branco, Mariana Garcia
collection PubMed
description Bioelectrical Impedance Analysis (BIA) is a reliable, non-invasive, objective, and cost-effective body composition assessment method, with high reproducibility. This scoping review aims to evaluate the current scientific and clinical evidence on BIA for body composition assessment in oncology patients, under active treatment. Literature search was conducted through MEDLINE, CINAHL, Scopus and Web of Science databases, following PRISMA-ScR Guidelines. Inclusion criteria comprised studies reporting the use of BIA for body composition evaluation in adults with cancer diagnosis. Studies including non-cancer pathology or only assessing nutritional status were excluded. This scoping review comprised a total of 36 studies: 25 were original studies including 18 prospective studies, six cross-sectional studies and one retrospective study and 11 were systematic reviews. Population size for the included original articles ranged from 18 to 1217 participants, comprising a total of 3015 patients with cancer with a mean baseline Body Mass Index (BMI) ranging from 20.3 to 30.0 kg/m(2) and mean age ranging between 47 and 70 years. Review articles included a total of 273 studies, with a total of 78,350 participants. The current review considered studies reporting patients with head and neck cancer (HNC) (n = 8), breast cancer (BC) (n = 4), esophageal cancer (EC) (n = 2), liver cancer (n = 2), pancreatic cancer (PC) (n = 3), gastric cancer (GC) (n = 3), colorectal cancer (CRC) (n = 8), lung cancer (LC) (n = 1), skin cancer (SK) (n = 1) and multiple cancer types (n = 6). BIA is a suitable and valid method for the assessment of body composition in oncology. BIA-derived measures have shown good potential and relevant clinical value in preoperative risk evaluation, in the reduction of postoperative complications and hospital stay and as an important prognostic indicator in persons with cancer. Future research on the diagnostic value and clinical applications of BIA and BIA-derived phase angle (PhA) should be conducted in order to predict its impact on patient survival and other clinical outcomes.
format Online
Article
Text
id pubmed-10675768
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106757682023-11-15 Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review Branco, Mariana Garcia Mateus, Carlota Capelas, Manuel Luís Pimenta, Nuno Santos, Teresa Mäkitie, Antti Ganhão-Arranhado, Susana Trabulo, Carolina Ravasco, Paula Nutrients Review Bioelectrical Impedance Analysis (BIA) is a reliable, non-invasive, objective, and cost-effective body composition assessment method, with high reproducibility. This scoping review aims to evaluate the current scientific and clinical evidence on BIA for body composition assessment in oncology patients, under active treatment. Literature search was conducted through MEDLINE, CINAHL, Scopus and Web of Science databases, following PRISMA-ScR Guidelines. Inclusion criteria comprised studies reporting the use of BIA for body composition evaluation in adults with cancer diagnosis. Studies including non-cancer pathology or only assessing nutritional status were excluded. This scoping review comprised a total of 36 studies: 25 were original studies including 18 prospective studies, six cross-sectional studies and one retrospective study and 11 were systematic reviews. Population size for the included original articles ranged from 18 to 1217 participants, comprising a total of 3015 patients with cancer with a mean baseline Body Mass Index (BMI) ranging from 20.3 to 30.0 kg/m(2) and mean age ranging between 47 and 70 years. Review articles included a total of 273 studies, with a total of 78,350 participants. The current review considered studies reporting patients with head and neck cancer (HNC) (n = 8), breast cancer (BC) (n = 4), esophageal cancer (EC) (n = 2), liver cancer (n = 2), pancreatic cancer (PC) (n = 3), gastric cancer (GC) (n = 3), colorectal cancer (CRC) (n = 8), lung cancer (LC) (n = 1), skin cancer (SK) (n = 1) and multiple cancer types (n = 6). BIA is a suitable and valid method for the assessment of body composition in oncology. BIA-derived measures have shown good potential and relevant clinical value in preoperative risk evaluation, in the reduction of postoperative complications and hospital stay and as an important prognostic indicator in persons with cancer. Future research on the diagnostic value and clinical applications of BIA and BIA-derived phase angle (PhA) should be conducted in order to predict its impact on patient survival and other clinical outcomes. MDPI 2023-11-15 /pmc/articles/PMC10675768/ /pubmed/38004186 http://dx.doi.org/10.3390/nu15224792 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Branco, Mariana Garcia
Mateus, Carlota
Capelas, Manuel Luís
Pimenta, Nuno
Santos, Teresa
Mäkitie, Antti
Ganhão-Arranhado, Susana
Trabulo, Carolina
Ravasco, Paula
Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review
title Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review
title_full Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review
title_fullStr Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review
title_full_unstemmed Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review
title_short Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review
title_sort bioelectrical impedance analysis (bia) for the assessment of body composition in oncology: a scoping review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675768/
https://www.ncbi.nlm.nih.gov/pubmed/38004186
http://dx.doi.org/10.3390/nu15224792
work_keys_str_mv AT brancomarianagarcia bioelectricalimpedanceanalysisbiafortheassessmentofbodycompositioninoncologyascopingreview
AT mateuscarlota bioelectricalimpedanceanalysisbiafortheassessmentofbodycompositioninoncologyascopingreview
AT capelasmanuelluis bioelectricalimpedanceanalysisbiafortheassessmentofbodycompositioninoncologyascopingreview
AT pimentanuno bioelectricalimpedanceanalysisbiafortheassessmentofbodycompositioninoncologyascopingreview
AT santosteresa bioelectricalimpedanceanalysisbiafortheassessmentofbodycompositioninoncologyascopingreview
AT makitieantti bioelectricalimpedanceanalysisbiafortheassessmentofbodycompositioninoncologyascopingreview
AT ganhaoarranhadosusana bioelectricalimpedanceanalysisbiafortheassessmentofbodycompositioninoncologyascopingreview
AT trabulocarolina bioelectricalimpedanceanalysisbiafortheassessmentofbodycompositioninoncologyascopingreview
AT ravascopaula bioelectricalimpedanceanalysisbiafortheassessmentofbodycompositioninoncologyascopingreview